p53 induces circFRMD4A to suppress cancer development through glycolytic reprogramming and cuproptosis
Molecular Cell · 2025-01 · 85 (1) · 132-149.e7
DOI: 10.1016/j.molcel.2024.11.013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Cell, 2025-01. Verfasst von Quan Liao und 16 weiteren Autor:innen. Beteiligte Einrichtung: Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, China; Department of Oncology, Shan…. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, Glycolysis, RNA, Circular. Die Arbeit wurde bisher 76-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: Innovative Research Team of High-level Local University in Shanghai, National Natural Science Foundation of China.
Abstract (Originalsprache)
Cuproptosis is a type of copper-induced cell death that mainly impacts cells relying on mitochondrial metabolism. Although p53 regulates glycolytic metabolism, its role in cuproptosis remains unclear. Here, we report that the circular RNA, circFRMD4A, is crucial for p53-mediated metabolic reprogramming and cuproptosis. CircFRMD4A originates from the transcript of FRMD4A, which is transcriptionally activated by p53, and the formation of circFRMD4A is facilitated by the RNA-binding protein EWSR1. CircFRMD4A functions as a tumor suppressor and enhances the sensitivity of cancer cells to elesclomol-induced cuproptosis. Mechanistic analysis reveals that circFRMD4A interacts with and inactivates the pyruvate kinase PKM2, leading to a decrease in lactate production and a redirection of glycolytic flux toward the tricarboxylic acid cycle. Finally, p53 agonists and elesclomol coordinately suppress the growth of cancer in a xenograft mouse model. Altogether, our study uncovers that p53 promotes glycolytic reprogramming and cuproptosis via circFRMD4A and suggests a potential combination strategy against cancers with wild-type p53.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China; Depart…
- Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, Jiangxi, China; Jiangxi Key Laboratory for Individual Cancer Therapy, Nanchang 330006, Jiangxi, China.
- Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
- Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, Jiangxi, China.
- Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
- Beijing Institute of Hepatology, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
Förderung
- Innovative Research Team of High-level Local University in Shanghai
- National Natural Science Foundation of China
Zitieren
APA
Liao, Q., Deng, J., Tong, J., Gan, Y., Hong, W., Dong, H., Cao, M., Xiong, C., Chen, Y., Xie, B., Yang, F. Y., Alifu, A., Zhou, G. B., Huang, S., Xiong, J., Hao, Q., & Zhou, X. (2025). p53 induces circFRMD4A to suppress cancer development through glycolytic reprogramming and cuproptosis. Molecular Cell, 85(1), 132-149.e7. https://doi.org/10.1016/j.molcel.2024.11.013
Vancouver
Liao Q, Deng J, Tong J, Gan Y, Hong W, Dong H, et al. p53 induces circFRMD4A to suppress cancer development through glycolytic reprogramming and cuproptosis. Molecular Cell. 2025;85(1):132-149.e7. doi:10.1016/j.molcel.2024.11.013
BibTeX
@article{Liao2025,
author = {Liao, Quan and Deng, Jun and Tong, Jing and Gan, Yu and Hong, Weiwei and Dong, Hanzhi and Cao, Mingming and Xiong, Chen and Chen, Yajie and Xie, Bangxiang and Yang, Fu-Ying and Alifu, Aikede and Zhou, Guang-Biao and Huang, Shenglin and Xiong, Jianping and Hao, Qian and Zhou, Xiang},
title = {p53 induces circFRMD4A to suppress cancer development through glycolytic reprogramming and cuproptosis},
journal = {Molecular Cell},
year = {2025},
volume = {85},
number = {1},
pages = {132--149.e7},
doi = {10.1016/j.molcel.2024.11.013}
}
EUVIMED